RecruitingNot ApplicableNCT06891586

Blood Phoenixin-14 Levels and Echocardiographic Findings in Infants of Diabetic Mothers

Investigation of the Relationship Between Phoenixin-14 Levels and Echocardiographic Findings in Infants of Diabetic Mothers

Sponsor

Konya City Hospital

Enrollment

84 participants

Start Date

Sep 1, 2024

Study Type

INTERVENTIONAL

Conditions

Newborn Morbidity Newborn Complication

Summary

In this study, the investigators hypothesize that echocardiographic pathologies observed in infants of diabetic mothers are associated with elevated serum phoenixin-14 levels.

Eligibility

Min Age: 1 DayMax Age: 5 Days

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying echocardiographic evaluation and blood phoenixin-14 level for people with newborn complication and newborn morbidity. The study is currently recruiting participants at 1 location. People eligible for this study include aged 1 Day to 5 Days.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTechocardiographic evaluation and blood phoenixin-14 level

For participants who provide consent, blood samples will be collected at 6 hours postpartum. Additionally, infants included in the study will undergo an echocardiographic evaluation by a pediatric cardiologist between postnatal days 3 and 5.

Locations(1)

Melek Buyukeren

Konya, Karatay, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06891586

Related Trials

Measuring Adverse Pregnancy and Newborn Congenital Outcomes

NCT044057001 location

Evaluation of Serial Lung Ultrasound Data After Surfactant Treatments Applied With Different Methods in Preterm Babies

NCT068800161 location